EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $46,807,000 | -2.0% | 31,841,394 | +0.0% | 18.49% | -4.8% |
| Q1 2022 | $47,750,000 | +108.4% | 31,833,334 | +247.3% | 19.42% | +102.5% |
| Q4 2021 | $22,917,000 | -51.2% | 9,166,667 | 0.0% | 9.59% | -56.2% |
| Q3 2021 | $46,933,000 | -38.4% | 9,166,667 | 0.0% | 21.90% | -41.0% |
| Q2 2021 | $76,175,000 | -4.6% | 9,166,667 | 0.0% | 37.14% | +23.9% |
| Q1 2021 | $79,842,000 | -19.8% | 9,166,667 | 0.0% | 29.97% | -1.9% |
| Q4 2020 | $99,550,000 | -9.0% | 9,166,667 | 0.0% | 30.54% | +86.3% |
| Q3 2020 | $109,358,000 | -25.7% | 9,166,667 | 0.0% | 16.39% | -42.4% |
| Q2 2020 | $147,217,000 | +3.5% | 9,166,667 | 0.0% | 28.46% | -35.5% |
| Q1 2020 | $142,175,000 | -13.3% | 9,166,667 | +37.5% | 44.14% | +19.0% |
| Q4 2019 | $164,000,000 | – | 6,666,667 | – | 37.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |